138 related articles for article (PubMed ID: 16939541)
1. Diabetic neuropathy - a further indication for phosphodiesterase type 5 inhibitors?
Oliver JJ
Int J Clin Pract; 2006 Sep; 60(9):1026-7. PubMed ID: 16939541
[No Abstract] [Full Text] [Related]
2. Hypertrophied right hearts get two for the price of one: can inhibiting phosphodiesterase type 5 also inhibit phosphodiesterase type 3?
Kass DA
Circulation; 2007 Jul; 116(3):233-5. PubMed ID: 17638937
[No Abstract] [Full Text] [Related]
3. Cyclic GMP and phosphodiesterase 5 inhibitor therapies: what's on the horizon?
Lincoln TM
Mol Pharmacol; 2004 Jul; 66(1):11-3. PubMed ID: 15213291
[No Abstract] [Full Text] [Related]
4. Salvage techniques for phosphodiesterase 5 inhibitor therapy: purposeful but how much?
Burnett AL
Eur Urol; 2006 Jul; 50(1):29-30. PubMed ID: 16567036
[No Abstract] [Full Text] [Related]
5. Pre-clinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms.
Hotston M; Shukla N; Bloor J; Persad R; Jeremy JY
BJU Int; 2006 Dec; 98(6):1331-2. PubMed ID: 17125493
[No Abstract] [Full Text] [Related]
6. Optimisation of PDE5 inhibitor therapy in men with erectile dysfunction: converting "non-responders" into "responders".
Eardley I
Eur Urol; 2006 Jul; 50(1):31-3. PubMed ID: 16517052
[No Abstract] [Full Text] [Related]
7. Modulatory effect of the PDE-5 inhibitor sildenafil in diabetic neuropathy.
Patil CS; Singh VP; Singh S; Kulkarni SK
Pharmacology; 2004 Nov; 72(3):190-5. PubMed ID: 15452368
[TBL] [Abstract][Full Text] [Related]
8. Review of time of onset and duration of clinical efficacy of phosphodiesterase type 5 inhibitors in treatment of erectile dysfunction.
Shabsigh R; Seftel AD; Rosen RC; Porst H; Ahuja S; Deeley MC; Garcia CS; Giuliano F
Urology; 2006 Oct; 68(4):689-96. PubMed ID: 17070333
[No Abstract] [Full Text] [Related]
9. Rates of non-arteritic ischemic optic neuropathy in male veterans prescribed phosphodiesterase-5 inhibitors.
Tsertsvadze A
Am J Ophthalmol; 2009 Oct; 148(4):625; author reply 625-6. PubMed ID: 19782802
[No Abstract] [Full Text] [Related]
10. Non-arteritic anterior ischemic optic neuropathy, PDE-5 inhibitors, and amiodarone: may there be a sex hormone effect for the eye?
Verit A
Med Hypotheses; 2007; 69(2):470-1. PubMed ID: 17280789
[No Abstract] [Full Text] [Related]
11. Efficacy of PDE-5-inhibitors for erectile dysfunction. A comparative meta-analysis of fixed-dose regimen randomized controlled trials administering the International Index of Erectile Function in broad-spectrum populations.
Rosen RC; Shaw JW
Int J Impot Res; 2006; 18(6):570-1; author reply 572-3. PubMed ID: 17075585
[No Abstract] [Full Text] [Related]
12. Rationale for androgens and erectile dysfunction in 2006.
Roumeguère T
Eur Urol; 2006 Nov; 50(5):898-900. PubMed ID: 16893603
[No Abstract] [Full Text] [Related]
13. [How I treat and manage erectile dysfunction in diabetics].
Buvat J
Journ Annu Diabetol Hotel Dieu; 2006; ():185-203. PubMed ID: 17051861
[No Abstract] [Full Text] [Related]
14. [Treatment of pulmonary arterial hypertension: phosphodiesterase-5 inhibitors].
Ghofrani HA; Grimminger F
Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S311-4. PubMed ID: 17139594
[TBL] [Abstract][Full Text] [Related]
15. PDE5 inhibition and fibrosis.
Corbin J
Int J Impot Res; 2005; 17(6):546. PubMed ID: 16258527
[TBL] [Abstract][Full Text] [Related]
16. [Chronic treatment with PDE-5 inhibitors is there anything more than treating erectile dysfunction?].
Vela Navarrete R; García Cardoso JV; López Farre A; Quesada Romero P; Pardo Montero M
Actas Urol Esp; 2007 Mar; 31(3):179-84. PubMed ID: 17658146
[No Abstract] [Full Text] [Related]
17. PDE-5 inhibitors lower portal and pulmonary pressure in portopulmonary hypertension.
Deibert P; Bremer H; Roessle M; Kurz-Schmieg AK; Kreisel W
Eur Respir J; 2007 Jan; 29(1):220-1. PubMed ID: 17197488
[No Abstract] [Full Text] [Related]
18. This paper continues Professor Adaikan's distinguished involvement in classical pharmacologic research of erectile physiology.
Pickard R
Eur Urol; 2007 Jul; 52(1):259-60. PubMed ID: 17616089
[No Abstract] [Full Text] [Related]
19. Phosphodiesterase type 5 inhibithors in older males.
Frajese GV; Pozzi F
J Endocrinol Invest; 2005; 28(11 Suppl Proceedings):112-5. PubMed ID: 16760638
[TBL] [Abstract][Full Text] [Related]
20. Erectile dysfunction drugs and nonarteritic anterior ischemic optic neuropathy.
Lee AG; Newman NJ
Am J Ophthalmol; 2005 Oct; 140(4):707-8. PubMed ID: 16226524
[No Abstract] [Full Text] [Related]
[Next] [New Search]
